NR
Nagarjuna Reddy Devireddy
About Nagarjuna Reddy Devireddy
Data last updated:
Nagarjuna Reddy Devireddy is a Director at Sylph Pharmaceutical Private Limited (since 2020) and Director at My3 Pharma Private Limited (since 2023). The companies operate in Pharma. The largest current company by reported revenue is Sylph Pharmaceutical Private Limited at ₹1.13 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 08 Sep 2020 | 2020 | ₹1.13 Cr (FY 2025) | Active | |
| Director | 03 Jul 2023 | 2023 | Active |
Board colleagues of Nagarjuna Reddy Devireddy
| Name | DIN | Company | Designation |
|---|---|---|---|
| Devi S L V K Lankalapalli | 08868584 | Sylph Pharmaceutical Private Limited | Director |
| Sricharan Pala | 08945209 | My3 Pharma Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Nagarjuna Reddy Devireddy
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nagarjuna Reddy Devireddy
Nagarjuna Reddy Devireddy currently holds 2 directorships: Sylph Pharmaceutical Private Limited (Director, since 08 Sep 2020, revenue ₹1.13 Cr (FY 2025)); My3 Pharma Private Limited (Director, since 03 Jul 2023).
Nagarjuna Reddy Devireddy was first appointed on 08 Sep 2020 as Director at Sylph Pharmaceutical Private Limited. The most recent appointment on record is 03 Jul 2023 at My3 Pharma Private Limited.
The current boards of Nagarjuna Reddy Devireddy's companies include Devi S L V K Lankalapalli (Sylph Pharmaceutical Private Limited), Sricharan Pala (My3 Pharma Private Limited).